Search Results - "LASZLOVSZKY, ISTVÁN" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial

Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial

by Németh, György, Dr, Laszlovszky, István, PharmD, Czobor, Pál, PhD, Szalai, Erzsébet, MD, Szatmári, Balázs, MD, Harsányi, Judit, MD, Barabássy, Ágota, MD, Debelle, Marc, MD, Durgam, Suresh, MD, Bitter, István, Prof, Marder, Stephen, Prof, Fleischhacker, W Wolfgang, Prof
Published in The Lancet (British edition) (18.03.2017)

Get full text

Journal Article

Cariprazine, A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety

Cariprazine, A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety

by Laszlovszky, István, Barabássy, Ágota, Németh, György
Published in Advances in therapy (01.07.2021)

Get full text

Journal Article

An 8-Week Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar I Depression

An 8-Week Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar I Depression

by Durgam, Suresh, Earley, Willie, Lipschitz, Alan, Guo, Hua, Laszlovszky, István, Németh, György, Vieta, Eduard, Calabrese, Joseph R., Yatham, Lakshmi N.
Published in The American journal of psychiatry (01.03.2016)

Get full text

Journal Article

An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: A phase II, randomized clinical trial

An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: A phase II, randomized clinical trial

by Durgam, Suresh, Starace, Anju, Li, Dayong, Migliore, Raffaele, Ruth, Adam, Németh, György, Laszlovszky, István
Published in Schizophrenia research (01.02.2014)

Get full text

Journal Article

The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial

The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial

by Durgam, Suresh, Starace, Anju, Li, Dayong, Migliore, Raffaele, Ruth, Adam, Németh, György, Laszlovszky, István
Published in Bipolar disorders (01.02.2015)

Get full text

Journal Article

The efficacy of cariprazine in negative symptoms of schizophrenia: Post hoc analyses of PANSS individual items and PANSS-derived factors

The efficacy of cariprazine in negative symptoms of schizophrenia: Post hoc analyses of PANSS individual items and PANSS-derived factors

by Fleischhacker, Wolfgang, Galderisi, Silvana, Laszlovszky, István, Szatmári, Balázs, Barabássy, Ágota, Acsai, Károly, Szalai, Erzsébet, Harsányi, Judit, Earley, Willie, Patel, Mehul, Németh, György
Published in European psychiatry (01.05.2019)

Get full text

Journal Article

Linking PANSS negative symptom scores with the Clinical Global Impressions Scale: understanding negative symptom scores in schizophrenia

Linking PANSS negative symptom scores with the Clinical Global Impressions Scale: understanding negative symptom scores in schizophrenia

by Leucht, Stefan, Barabássy, Ágota, Laszlovszky, István, Szatmári, Balázs, Acsai, Károly, Szalai, Erzsébet, Harsányi, Judit, Earley, Willie, Németh, György
Published in Neuropsychopharmacology (New York, N.Y.) (01.08.2019)

Get full text

Journal Article

Potential Mechanisms for Why Not All Antipsychotics Are Able to Occupy Dopamine D3 Receptors in the Brain in vivo

Potential Mechanisms for Why Not All Antipsychotics Are Able to Occupy Dopamine D3 Receptors in the Brain in vivo

by Kiss, Béla, Krámos, Balázs, Laszlovszky, István
Published in Frontiers in psychiatry (24.03.2022)

Get full text

Journal Article

Safety and tolerability of cariprazine in patients with acute exacerbation of schizophrenia: a pooled analysis of four phase II/III randomized, double-blind, placebo-controlled studies

Safety and tolerability of cariprazine in patients with acute exacerbation of schizophrenia: a pooled analysis of four phase II/III randomized, double-blind, placebo-controlled studies

by Earley, Willie, Durgam, Suresh, Lu, Kaifeng, Laszlovszky, István, Debelle, Marc, Kane, John M
Published in International clinical psychopharmacology (01.11.2017)

Get more information

Journal Article

Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial

Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial

by Durgam, Suresh, Earley, Willie, Li, Rui, Li, Dayong, Lu, Kaifeng, Laszlovszky, István, Fleischhacker, W. Wolfgang, Nasrallah, Henry A
Published in Schizophrenia research (01.10.2016)

Get full text

Journal Article

Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trial

Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trial

by Fava, Maurizio, Durgam, Suresh, Earley, Willie, Lu, Kaifeng, Hayes, Robert, Laszlovszky, István, Németh, György
Published in International clinical psychopharmacology (01.11.2018)

Get more information

Journal Article

Disentangling the symptoms of schizophrenia: Network analysis in acute phase patients and in patients with predominant negative symptoms

Disentangling the symptoms of schizophrenia: Network analysis in acute phase patients and in patients with predominant negative symptoms

by Demyttenaere, Koen, Leenaerts, Nicolas, Acsai, Károly, Sebe, Barbara, Laszlovszky, István, Barabássy, Ágota, Fonticoli, Laura, Szatmári, Balázs, Earley, Willie, Németh, György, Correll, Christoph U
Published in European psychiatry (13.10.2021)

Get full text

Journal Article

Efficacy of cariprazine across symptom domains in patients with acute exacerbation of schizophrenia: Pooled analyses from 3 phase II/III studies

Efficacy of cariprazine across symptom domains in patients with acute exacerbation of schizophrenia: Pooled analyses from 3 phase II/III studies

by Marder, Stephen, Fleischhacker, W. Wolfgang, Earley, Willie, Lu, Kaifeng, Zhong, Yan, Németh, György, Laszlovszky, István, Szalai, Erzsébet, Durgam, Suresh
Published in European neuropsychopharmacology (01.01.2019)

Get full text

Journal Article

Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [11C]-(+)-PHNO

Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [11C]-(+)-PHNO

by Girgis, Ragy R., Slifstein, Mark, D’Souza, Deepak, Lee, Yih, Periclou, Antonia, Ghahramani, Parviz, Laszlovszky, István, Durgam, Suresh, Adham, Nika, Nabulsi, Nabeel, Huang, Yiyun, Carson, Richard E., Kiss, Béla, Kapás, Margit, Abi-Dargham, Anissa, Rakhit, Ashok
Published in Psychopharmacology (01.10.2016)

Get full text

Journal Article

Tolerability of Cariprazine in the Treatment of Acute Bipolar I Mania: A Pooled Post Hoc Analysis of 3 Phase II/III Studies

Tolerability of Cariprazine in the Treatment of Acute Bipolar I Mania: A Pooled Post Hoc Analysis of 3 Phase II/III Studies

by Earley, Willie, Durgam, Suresh, Lu, Kaifeng, Debelle, Marc, Laszlovszky, István, Vieta, Eduard, Yatham, Lakshmi N
Published in Journal of affective disorders (01.06.2017)

Get full text

Journal Article

Clinically relevant response and remission outcomes in cariprazine-treated patients with bipolar I disorder

Clinically relevant response and remission outcomes in cariprazine-treated patients with bipolar I disorder

by Earley, Willie, Durgam, Suresh, Lu, Kaifeng, Ruth, Adam, Németh, György, Laszlovszky, István, Yatham, Lakshmi N.
Published in Journal of affective disorders (15.01.2018)

Get full text

Journal Article

Comment on: “Clinical Pharmacokinetics of Atypical Antipsychotics: An Update”

Comment on: “Clinical Pharmacokinetics of Atypical Antipsychotics: An Update”

by Periclou, Antonia, Riccobene, Todd, Kapás, Margit, Laszlovszky, István
Published in Clinical pharmacokinetics (01.09.2019)

Get full text

Journal Article

Cariprazine in the treatment of schizophrenia: a proof-of-concept trial

Cariprazine in the treatment of schizophrenia: a proof-of-concept trial

by Durgam, Suresh, Litman, Robert E, Papadakis, Kelly, Li, Dayong, Németh, György, Laszlovszky, István
Published in International clinical psychopharmacology (01.03.2016)

Get more information

Journal Article

Evaluation of the long-term safety and tolerability of cariprazine in patients with schizophrenia: results from a 1-year open-label study

Evaluation of the long-term safety and tolerability of cariprazine in patients with schizophrenia: results from a 1-year open-label study

by Cutler, Andrew J., Durgam, Suresh, Wang, Yao, Migliore, Raffaele, Lu, Kaifeng, Laszlovszky, István, Németh, György
Published in CNS spectrums (01.02.2018)

Get full text

Journal Article

The safety and tolerability of cariprazine in patients with manic or mixed episodes associated with bipolar I disorder: A 16-week open-label study

The safety and tolerability of cariprazine in patients with manic or mixed episodes associated with bipolar I disorder: A 16-week open-label study

by Ketter, Terence A., Sachs, Gary S., Durgam, Suresh, Lu, Kaifeng, Starace, Anju, Laszlovszky, István, Németh, György
Published in Journal of affective disorders (01.01.2018)

Get full text

Journal Article

1
2
3
4
5
6
7
8
9
10
11
Next
[20]